Deutsche Bank’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,122
| Closed | -$44.5K | – | 3642 |
|
|
2025
Q1 | $44.5K | Hold |
4,122
| – | – | ﹤0.01% | 3364 |
|
|
2024
Q4 | $52.8K | Hold |
4,122
| – | – | ﹤0.01% | 3361 |
|
|
2024
Q3 | $114K | Buy |
4,122
+1,206
| +41% | +$33.3K | ﹤0.01% | 3131 |
|
|
2024
Q2 | $84.6K | Sell |
2,916
-710
| -20% | -$20.6K | ﹤0.01% | 3132 |
|
|
2024
Q1 | $162K | Buy |
3,626
+126
| +4% | +$5.62K | ﹤0.01% | 2906 |
|
|
2023
Q4 | $136K | Sell |
3,500
-116
| -3% | -$4.5K | ﹤0.01% | 3033 |
|
|
2023
Q3 | $106K | Buy |
3,616
+605
| +20% | +$17.8K | ﹤0.01% | 3108 |
|
|
2023
Q2 | $192K | Sell |
3,011
-2,287
| -43% | -$145K | ﹤0.01% | 2896 |
|
|
2023
Q1 | $250K | Buy |
5,298
+1,552
| +41% | +$73.3K | ﹤0.01% | 2896 |
|
|
2022
Q4 | $260K | Buy |
3,746
+57
| +2% | +$3.96K | ﹤0.01% | 2802 |
|
|
2022
Q3 | $541K | Sell |
3,689
-401
| -10% | -$58.8K | ﹤0.01% | 2318 |
|
|
2022
Q2 | $533K | Buy |
4,090
+45
| +1% | +$5.86K | ﹤0.01% | 2544 |
|
|
2022
Q1 | $409K | Buy |
4,045
+3,328
| +464% | +$337K | ﹤0.01% | 2851 |
|
|
2021
Q4 | $111K | Buy |
717
+37
| +5% | +$5.73K | ﹤0.01% | 3606 |
|
|
2021
Q3 | $201K | Buy |
+680
| New | +$201K | ﹤0.01% | 3536 |
|